CEA is the most common used serum biomarker for cancer screening and the diagnosis of NSCLC, cytokeratin-19 fragment (CYFRA21-1) is also applied in NSCLC detection clinically9-12. Here, CEACAM5 is linked to non-small cell lung carcinoma.